Mounjaro: As Eli Lilly's blockbuster anti-obesity drug comes to India, expert lists key side effects
Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, approved by CDSCO, helps with we ...
Popular Type 2 diabetes medicine Mounjaro released in India
Eli Lilly launches Mounjaro in India addressing diabetes-obesity crisis. Approved by CDSCO yet high costs limit accessibility ...
Frontiers22h
Interdisciplinary Research in Diabetology
The prevalence of diabetes has alarmingly increased in both developed and developing countries in recent years. The ...